NDC00093-9114-01: PROCAINAMIDE HYDROCHLORIDE EXTEN.
PROCAINAMIDE HYDROCHLORIDE EXTEN. Key specifications include primary_container_type: BOTTLE, therapeutic_equivalent: PARKE-DAVIS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 100.000 TABLETS, active_medicament_medicinal_strength: 750.000 MILLIGRAMS PROCAINAMIDE HYDROCHLORIDE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: PROCAINAMIDE HYDROCHLORIDE EXTENDED-RELEASE TABLETS USP 750MG 100S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-146-5337, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| primary_container_type | BOTTLE |
| therapeutic_equivalent | PARKE-DAVIS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 100.000 TABLETS |
| active_medicament_medicinal_strength | 750.000 MILLIGRAMS PROCAINAMIDE HYDROCHLORIDE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | PROCAINAMIDE HYDROCHLORIDE EXTENDED-RELEASE TABLETS USP 750MG 100S |
| NSN | 6505-01-146-5337 |
| THERAPEUTIC EQUIVALENT | PARKE-DAVIS |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | PROCAINAMIDE HYDROCHLORIDE EXTENDED-RELEASE TABLETS USP 750MG 100S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 750.000 MILLIGRAMS PROCAINAMIDE HYDROCHLORIDE ACTIVE INGREDIENT |
No substitute or cross-reference records for this part.